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Class I PI 3-kinaseThe evolutionarily conserved PIKfyve, which synthesizes PtdIns5P from PtdIns, and PtdIns(3,5)P2 from PtdIns3P,
requires PtdIns3P as both an enzyme substrate and amembrane recruitment signal.Whereas the PtdIns3P source
is undetermined, class III PI3K (Vps34), the only evolutionarily conserved of the eight mammalian PI3Ks, is
presumed as amain candidate. A hallmark of PIKfyve deﬁciency is formation ofmultiple translucent cytoplasmic
vacuoles seen by light microscopy in cells cultured in complete media. Such an aberrant phenotype is often
observed in cells from conditional Vps34 knockout (KO) mice. To clarify the mechanism of Vps34 KO-triggered
vacuolation and the PtdIns3P source for PIKfyve functionality, here we have characterized a podocyte cell type
derived from Vps34ﬂ/ﬂ mice, which, upon Cre-mediated gene KO, robustly formed cytoplasmic vacuoles
resembling those in PikfyveKOMEFs. Vps34wt, expressed inVps34KOpodocytes restored the normalmorphology,
but only if the endogenous PIKfyve activity was intact. Conversely, expressed PIKfyvewt rescued completely the
vacuolation only in PikfyveKO MEFs but not in Vps34KO podocytes. Analyses of phosphoinositide proﬁles by
HPLC and localization patterns by a PtdIns3P biosensor revealed that Vps34 is the main supplier of localized
PtdIns3P not only for PIKfyve activity but also for membrane recruitment. Concordantly, Vps34KO podocytes
had severely reduced steady-state levels of both PtdIns(3,5)P2 and PtdIns5P, along with PtdIns3P.We further re-
vealed a plausible physiologically-relevant Vps34-independent PtdIns3P supply for PIKfyve, operating through
activated class I PI3Ks. Our data provide the ﬁrst evidence that the vacuolation phenotype in Vps34KO podocytes
is due to PIKfyve dysfunction and that Vps34 is a main PtdIns3P source for constitutive PIKfyve functionality.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
PIKfyve is an evolutionarily conserved kinase that is a product
of a single gene in metazoans. Mammalian PIKfyve, synthesizing phos-
phatidylinositol (PtdIns)1 5P from PtdIns, and PtdIns(3,5)P2 fromayne State University School of
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ffer.PtdIns3P, represents a major node in PI signaling and membrane
trafﬁcking downstream of PtdIns3P [1]. PIKfyve controls both constitu-
tive and regulated endocytic trafﬁcking as evidenced by the presence
of its lipid products in quiescent cells and their elevation upon activa-
tion of endosome dynamics by cues such as insulin, EGF or viral
infection [2–8]. A hallmark of PIKfyve cellular inactivation, achieved
by means of PIKfyve dominant-negative kinase-deﬁcient mutants
[9,10], pharmacological inhibition [5,11,12], siRNA-mediated silenc-
ing [13] or Cre-mediated gene disruption [14,15], is progressive
dilation of endosomal membranes, culminating in the appearance
of multiple translucent cytoplasmic vacuoles readily seen by light
microscopy in dividing cells grown in complete media. Because the
vacuoles are selectively rescued by cytoplasmic microinjections of
PtdIns(3,5)P2 but not PtdIns5P [10], the aberrant phenotype
has been widely used as a sensitive intracellular indicator for selec-
tive PIKfyve-dependent PtdIns(3,5)P2 deﬁciency [reviewed in [1,2]].
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rate-limiting function of the PIKfyve-catalyzed PtdIns3P to PtdIns(3,5)
P2 conversion in the course of early endosome maturation, controlling
cargo exit from early endosomes and progression of endocytic
trafﬁcking [1,2].
The PtdIns3P-producing enzyme(s) supplying the PtdIns3P
substrate for the PIKfyve lipid kinase activity is (are) not yet delineated.
Likewise, whereas it is well established that PtdIns3P is a major
targeting signal for PIKfyve recruitment to Rab5GTP-organized
endosome platforms [16,17], whether it is generated by the same
enzyme supplying the substrate awaits clariﬁcation. Based on
the fact that, like PIKfyve, human Vps34, a class III phosphatidylinositol
3-kinase (gene symbol PIK3C3) is evolutionarily conserved, with the
orthologous Vps34 being the only PtdIns3P-synthesizing enzyme in Sac-
charomyces cerevisiae [18], its role as a main PtdIns3P source for both
PIKfyve activity and localization has been presumed but never studied.
Indeed, the vesicular localization pattern of PIKfyve is rendered diffuse
in several cell types treated with low concentrations of wortmannin, a
powerful catalytic inhibitor of Vps34 [13,16,17]. However, inmetazoans,
PtdIns3P is also produced byVps34-independentmechanismsoperating
through class I and class II PI3Ks. For example, PtdIns(3,4,5)P3, made at
the internal leaﬂet of the plasma membrane by activated wortmannin-
sensitive class I PI3Ks [19,20], might serve as a source of endosomal
PtdIns3P subsequent to two consecutive dephosphorylation reactions
by the PI 5- and 4-phosphatases [21,22]. Likewise, class II PI3Ks produce
PtdIns3P directly from PtdIns and, indirectly, by 3-phosphorylation of
PtdIns4P followed by 4-dephosphorylation of PtdIns(3,4)P2 [23–25],
with class II PI3Kβ also being wortmannin-sensitive [26].
Strikingly, Vps34 perturbation by siRNA silencing or delivery of
inhibitory antibodies causes cytoplasmic vacuolation resembling that
seen upon PIKfyve dysfunction [27–29]. Similarly, primary cells derived
from recently developed mouse models with conditional Vps34 gene
disruption also demonstrate the aberrant phenotype of translucent
cytoplasmic vacuoles, which often occurs in the absence of autopha-
gic abnormalities [30–32]. Hence, an outstanding question awaiting
clariﬁcation is whether the aberrant endomembrane phenotype in
cells with ablated Vps34-catalyzed PtdIns3P pool is due to arrested
downstream signaling by PIKfyve.
Here we used podocytes with Vps34 Cre recombinase-mediated
gene disruption in combination with a rescue approach to unravel the
functional relationship between PIKfyve and Vps34 lipid kinases and
their role in endomembrane homeostasis. MEFs with Pikfyve Cre
recombinase-mediated gene disruption were used as reference.
We identiﬁed that PtdIns3P generated by Vps34 serves as both a
major precursor for PtdIns(3,5)P2 synthesis and a membrane localiza-
tion target of PIKfyve in resting cells. We clariﬁed that disrupted
endomembrane homeostasis in Vps34KOpodocytes is due to an ablated
Vps34-controlled PtdIns3P pool and consequent abrogation of PIKfyve-
catalyzed PtdIns(3,5)P2 and PtdIns5P production. We further revealed
that activated class I PI3Ks could contribute to some extent to the
regulation of endomembrane homeostasis.
2. Materials and methods
2.1. Cell lines
Pikfyve and Vps34 (ﬂ/ﬂ orwt/wt)MEFswere isolated from E12.5 em-
bryos derived from the transgenic mousemodels [14,33] following pre-
viously described procedures [14]. Glomerular cells were isolated from
kidneys of Vps34ﬂ/ﬂ mice [33]. Brieﬂy, removed kidneys were chopped
on ice into ﬁne pieces and then passed through sieves in a laminar
ﬂowhood. Small pieceswere ﬁrst passed through a 70 μmsieve (BD Fal-
con) and collected in a 50ml tube. A sterile syringe plunger was used to
push the small pieces through the sieve. Following thorough rinseswith
sterile PBS, thematerialwas collected and then passed through a second
50 μm sieve, followed by rinses with PBS. The material on top of the50 μm sieve was transferred to a 50 ml tube and then spun down to
form a pellet. Cells, resuspended in RPMI supplemented with insulin,
transferrin and selenium (each at 1%), and containing 50 U/ml penicil-
lin/50 μg/ml streptomycin, were seeded on 10 cm tissue-culture plates.
Plates were incubated at 37 °C for 10–15 days with media change
every 3–4 days. Cellular outgrowths were visible at days 6–8 and pre-
dominantly consisted of podocytes, with only a minor presence of
mesangial and endothelial cells [34,35]. Hence, the glomerular cells
are hereafter referred to as podocytes. Cells were then trypsinized
and seeded on fresh culture plates for 24–48 h. Cells were then
immortalized using SV40 T antigen, packaged in a Retro Viral vector
(MMLV-SV40-VSVG), and serum-free DMEM/RPMI media containing
polybrene (8 μg/ml) as previously described [34]. Primary cells or
transiently transfected cells stopped dividing after a few rounds of
sub-culturing and therefore further selection was not required.
Podocytes used in this study were derived from two Vps34ﬂ/ﬂ mice
(#3176 and #3061) and showed similar results. Control podocytes
were from the Vps34wt/wt mouse (#3175). All experiments were
performed with cells between 3 and 5 passages. Unless indicated, all
cell types were maintained in complete DMEM, containing 10% FBS,
50 U/ml penicillin and 50 μg/ml streptomycin sulfate.
2.2. Adenoviral transduction and transient transfection
Cells were treated with recombinant adenovirus expressing Cre
recombinase (Ad–Cre) or empty Ad (titer 1.3 × 1011; Vector Core,
University of Michigan, Ann Arbor), dissolved in complete media at
MOI=200 and aminimal volume covering the cells. 4 h later, complete
media was added to a volume optimal for the dish size. Media was
replaced 14 h later with fresh complete media. Pikfyve KO MEFs
(100 mm conﬂuent dishes) were transfected on day 4 post-Ad–Cre
treatment by electroporation using 50 μg of pEGFP–2xFYVEPIKfyve[14]
or pTag–YFP–Vps34wt cDNAs under a single pulse of 975 μF and
0.16 kV (Biorad-Gene pulser II) as described previously [36]. Vps34 KO
podocytes were transfected with the above cDNAs by Lipofectamine
3000 transfection kit (Invitrogen) following manufacturer protocols.
Where indicated, 24 h posttransfection, Vps34 KO podocytes were
treated (60min; 37 °C)with 1 μMof the YM201636 inhibitor (Symansis
NZ) dissolved in DMSO or only with vehicle.
Recombinant adenoviruses expressing HA–PIKfyvewt and GFP
from separate CMV promoters (AdGFP–PIKfyvewt) or only GFP
(AdGFP) were used at MOI = 10, with MOI = 1, being the lowest
dilution reaching 100% infection efﬁciency in HEK293 cells for
14 h [9]. The chosen MOI delivered infection in ~20–25% of the
total Pikfyve KO or Vps34 KO cells, the non-infected cells on the
same dish thereby serving as controls.
2.3. Light, ﬂuorescence and electron microscopy analyses
Cells, live or ﬁxed in 4% formaldehyde for 30 min, were viewed at
200× or 400× magniﬁcation with a Nikon Eclipse TE200 inverted
ﬂuorescence microscope as speciﬁed in the ﬁgure legends. Images
were captured with a SPOT RT Slider charge-coupled device camera
(Diagnostic Instruments). Cells expressing eGFP–2xFYVEPIKfyve
or YFP–Vps34wt were visualized by phase-contrast and ﬂuorescence
microscopy using a standard green channel [14,17]. Cells exhibiting
at least 5 perinuclear translucent vacuoles were considered as
vacuolated. Under each experimental design, 20–100 cells were
counted in 3–4 separate experiments. For electron microscopy
analyses, Ad or Ad–Cre-treated Vps34ﬂ/ﬂ podocytes grown in
complete media (10 cm dish) were trypsinized and pelleted at
4000 g for 5 min. Cell pellets were washed with PBS and ﬁxed in a
Sorenson's buffer (0.1 M), containing 2% paraformaldehyde and 2.5%
glutaraldehyde, again washed with PBS and ﬁxed using 1% osmium
tetroxide. Cell pellets were dehydrated in different strengths of
ethanol followed by propylene oxide. After embedding in a resin,
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and stained with 2% aqueous uranyl acetate and lead citrate
solutions. For imaging, a Philips CM-100 transmission electron
microscope equipped with compustage and high resolution
(2 K × 2 K) digital camera was used at the University of Michigan
core imaging facility.2.4. Myo-[2-3H] inositol cell labeling, lipid extraction and HPLC analyses
Vps34ﬂ/ﬂ podocytes (35 mm dishes) were treated with Ad–Cre or
empty Ad viruses as speciﬁed above. On day 4, cells were washed two
times with inositol/glucose-free DMEM, containing 5% dialyzed FBS,
0.5% BSA, 5 μg/ml insulin and 5 μg/ml transferrin, 2 mM pyruvate,
25 mM HEPES, pH 7.4, and 100 units/ml penicillin and 100 μg/ml
streptomycin for 24 h. Cells were then labeled with 25 μCi/ml myo-
[2-3H]inositol (Perkin Elmer) in a fresh media, as detailed above,
for 26 h. Cellular lipids were extracted, deacylated, and analyzed by
HPLC (Waters 5215) on a 5 μm Partisphere SAX column (Whatman)
as we described previously [5,7,14,37]. [32P]GroPIns5P, [32P]GroPIns3P,
[32P]GroPIns(4,5)P2 and [32P]GroPIns(3,5)P2 prepared by enzymatic
synthesis with [γ-32P]-ATP were used as HPLC standards as described
elsewhere [5,7,14,37]. Fractions were collected every 0.25 min and
analyzed for [3H] and [32P] radioactivity after addition of scintillation
mixture. Data evaluation and documentation was performed by
Microsoft EXCEL software. Individual peak radioactivity was quantiﬁed
by area integration and presented as a percentage of the summed
radioactivity from the [3H]-GroPIns3P, -4P, -5P, -(3,5)P2 and -(4,5)P2
peaks (“total radioactivity”).2.5. Western blot analysis
Cells were scraped in RIPA+ buffer [(composed of 50 mM Tris HCl,
pH 8.0, 150 mM NaCl, 1% Nonidet P-40 and 0.5% Na deoxycholate),
supplemented with 1× protease inhibitors [14]]. Proteins (60–150 μg/
lane) were separated by PAGE, transferred onto nitrocellulose
membrane and probed with previously characterized polyclonal
antibodies against Vps34 [a gift from Jon Backer [38]], Sac3 [37], PIKfyve
[R7069 [39]] and anti-GDI1 [40].2.6. Immunoprecipitation and in vitro PI3K activity assay
Fresh lysates from Vps34 KO podocytes, treated with or without Ad–
GFP for 16 h, were collected in RIPA++ buffer containing 1× protease
and 1× phosphatase inhibitor cocktails as described [41]. Precleared
lysates (20,000 ×g, 15 min, 4 °C) were subjected to immunoprecipita-
tion with rabbit polyclonal anti-p85 or mouse monoclonal anti-
phosphotyrosine antibodies (4G10), both from EMD Millipore.
The in vitro PI3K activity assay was conducted essentially as we
described previously [42] and detailed in Supplementary Experimental
Procedures.2.7. Other assays and statistics
Protein concentration was determined by bicinchoninic acid protein
assay. Protein and lipid levels on the blots and TLC plates, respectively,
were quantiﬁed by laser scanning densitometry (Epson V700) and
UN-SCAN-IT software (Silk Scientiﬁc). Several ﬁlms of different
exposure times were analyzed to assure that the signals were within
the linear range of detection sensitivity. Data are presented as mean
+/− SE. Statistical analysis of variance was performed by t test for
independent samples and a one-tail t test for paired samples, with
p b 0.05 considered statistically signiﬁcant.3. Results
3.1. Identiﬁcation of Vps34 KO cells robustly forming cytoplasmic vacuoles
in complete culture media
Along with PIKfyve protein loss, the excision of the ﬂoxed alleles in
MEFs isolated from Pikfyveﬂ/ﬂmice triggered progressively exacerbating
cytoplasmic vacuolation 3–5 days posttransfection with GFP–Cre
recombinase, readily visible by light microscopy of cells cultured in
complete (serum-containing) media, as we have previously reported
[14]. This result was extended herein for cells transduced with
adenovirus expressing Cre recombinase, whereby only Pikfyveﬂ/ﬂ
but not the Pikfyvewt/wt MEFs showed a profound vacuolation
phenotype, reaching ~90% on the 5th day posttransduction (Fig. 1A
and B). PIKfyve protein levels were undetectable under these
conditions (Fig. 1D). By contrast, control Pikfyveﬂ/ﬂ MEFs infected
with empty adenovirus displayed only a very low % of vacuolating
cells (b2%, Fig. 1A, panel b) until the end of the 7-day observation.
To begin elucidating the functional relationship between the
enzymatic products of Vps34 and PIKfyve as well as their role in
endomembrane homeostasis, we aimed at identifying a Vps34ﬂ/ﬂ
cell type that, upon Ad–Cre treatment would exhibit a robust time-
course of cell vacuolation as seen in Pikfyveﬂ/ﬂ — Ad–Cre-treated MEFs.
Surprisingly, examination of primary Vps34ﬂ/ﬂ MEFs showed only 10
and 25% vacuolating cells on days 5 and 7 posttransduction, respectively
(Fig. 1B). Consistently, an independent study [43] inMEFs, derived from
the sameVps34ﬂ/ﬂmousemodel used herein [33], also revealed aberrant
vacuolation only upon prolonged treatment with Cre recombinase.
Conversely, Ad–Cre transduction of immortalized Vps34ﬂ/ﬂ podocytes
resulted in formation of translucent cytoplasmic vacuoles at a pace
similar to that observed in Ad–Cre-treated Pikfyveﬂ/ﬂ MEFs (Fig. 1A and
B). Indeed, as high as 90% of the Vps34ﬂ/ﬂ podocytes cultured in com-
plete media exhibited cytoplasmic vacuoles at day 5 post-Ad–Cre treat-
ment, which were readily seen by light microscopy (Fig. 1A, panel c and
B). Our observation for robust cytoplasmic vacuolation in podocytes
with Vps34 ablation conﬁrms and extends previous ﬁndings in primary
podocytes isolated from podocyte-speciﬁc KO mice [31], generated
from the same conditional Vps34ﬂ/ﬂ mouse model used herein [33]. Of
note, control Vps34ﬂ/ﬂ or Vps34wt/wt podocytes transduced with empty
Ad or Ad–Cre, respectively, demonstrated a negligible number of
vacuolating cells (b2%; Fig. 1A, panel d, and B).
In addition to a similar pace of vacuole appearance in the two
cell types, electron microscopy revealed that, similarly to
HEK293 cells with impaired PIKfyve activity [44], the cytoplasmic
vacuoles formed in Vps34ﬂ/ﬂ podocytes at 5–6 days post-Cre-
infection were surrounded by a single-membrane and were largely
empty inside (Fig. 1C). This indicates that the swollen vacuoles in
podocytes with Vps34 ablation, as in the case with PIKfyve [44],
are distinct from autophagosome structures induced by serum
starvation. Even under conditions of 24 h serum starvation, the
morphology in Vps34ﬂ/ﬂ podocytes remained normal by light
microscopy (Fig. S1). Notably, the exclusion of the Oil red O lipid
marker from vacuoles in both Pikfyveﬂ/ﬂ MEFs and Vps34ﬂ/ﬂ
podocytes at 5–6 days post-Ad–Cre treatment indicated that the
translucent vacuoles were not lipid droplets (Fig. S2).
Ad–Cre transduction led to drastic and selective decreases of
Vps34 protein levels in Vps34ﬂ/ﬂ podocytes 5–6 days post-
treatment, thus conﬁrming the expected complete gene disruption
(Fig. 1D). Importantly, after day 7 of Ad–Cre treatment, vacuolated
Vps34ﬂ/ﬂ podocytes showed progressively reduced viability, with
most of them demising by day 10 likely through apoptosis, as deter-
mined in cultured primary podocytes isolated from the podocyte-
speciﬁc Vps34 KO mouse model [31].
Considering these similarities and limitations, detailed above,
we focused our study on Vps34ﬂ/ﬂ podocytes and Pikfyveﬂ/ﬂ MEFs
at days 5–6 after Ad–Cre treatment (referred to further as Vps34
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these conditions revealed that PIKfyve was not signiﬁcantly affect-
ed in Vps34 KO podocytes, nor was Sac3 (Fig. 1D), the 5-Fig. 1.Genedisruption ofVps34 inpodocytes andof Pikfyve inMEFs triggers cytoplasmic vacuolat
or Vps34wt/wt podocytes and Vps34ﬂ/ﬂMEFs cultured in complete media were treatedwith adeno
tative phase-contrast images, taken5 dayspost-treatment depicting similarmultiple translucent
c). Bar, 10 μm. B, time-course quantiﬁcation of cytoplasmic vacuolation subsequent to Ad–Cre tr
podocytes, reaching ~90% of total cells at days 5–6, weak cytoplasmic vacuolation (~25% of total
no vacuoles in Ad–Cre-treated Pikfyvewt/wt or Vps34wt/wt cells. Quantiﬁcation of the vacuolating
ments (mean ± SE). C, Vps34ﬂ/ﬂ podocytes maintained in complete media and treated with Ad
uoles surrounded by a single membrane, containing only few intraluminal vesicles, are observed
MVBs are visible (black arrowheads) containing multilamellar membrane whorls and intralum
iments with similar results. m,mitochondria (white arrows), n, nucleus. Bar, 0.5 μm. D,Western
against the indicated proteins conﬁrms complete and selective ablation of only the targeted ge
Shown are representative blots out of three to six independent experiments with similar result
indicating equal loading; Arrowhead, the Vps34 protein band.phosphatase that associates with PIKfyve and is potentially able
to modulate the PtdIns3P pool [1]. Similarly, Vps34 protein levels
were unaltered in Pikfyve KO MEFs (Fig. 1D). Likewise, in Pikfyveion at a similar pace.Pikfyveﬂ/ﬂ or Pikfyvewt/wtmouse embryonicﬁbroblasts (MEFs),Vps34ﬂ/ﬂ
virus, either empty (Ad) or expressing full-length Cre recombinase (Ad–Cre). A, represen-
cytoplasmic vacuoles innearly all Ad–Cre-treatedPikfyveﬂ/ﬂ andVps34ﬂ/ﬂ cells (panels a and
eatment showing similar precipitous vacuolation progression in Pikfyveﬂ/ﬂMEFs or Vps34ﬂ/ﬂ
cells at day 7 post-Ad–Cre, but increasing thereafter) in Ad–Cre-treated Vps34ﬂ/ﬂMEFs and
cells was obtained by counting N100 cells per condition per cell type in 3 separate experi-
or Ad–Cre (6 days) were observed by electron microscopy. Large-sized dilated empty vac-
only in Vps34 KO podocytes. In contrast, in control Vps34ﬂ/ﬂ podocytes, single-membraned
inal vesicles. Micrographs are representative of 30–60 images out of 2 independent exper-
blot analysis of lysates derived from indicated cells on day 5 postinfection using antibodies
ne products by Ad–Cre. Sac3 phosphatase levels are unaltered by Pikfyve KO or Vps34 KO.
s. GDI1, loading control; *, unspeciﬁc bands recognized by the anti-Vps34 antibodies, also
Fig. 2. PIKfyve dysfunction inVps34KOpodocytes underlies the aberrant vacuolation. On day
4 post-Ad–Cre-treatment, Vps34 KO podocytes (panels a–d) and Pikfyve KO MEFs (panels e
and f) were transfected with pTag–YFP–Vps34wt cDNA. 24 h post-transfection cells were
treated with vehicle (panels a, b, e and f) or 1 μm YM201636 for 1 h (panels c, d and not
shown). A, live cells were observed by ﬂuorescence microscopy and phase-contrast. Shown
are representative images of transfected cells (panels a, c and e) and the overlay with the
phase-contrast images (panels b, d and f). Rescue of the vacuolation phenotype occurs in
Vps34 KO podocytes upon YFP–Vps34wt expression (panels a and b) in practically all
transfected cells (see B). If endogenous PIKfyve activity is inhibitedbyYM201636 such rescue
is not observed (panels c and d). As expected, YFP–Vps34wt expression in Pikfyve KO MEFs
did not prevent the cytoplasmic vacuolation (panels e and f). Bar, 10 μm. B, Quantiﬁcation
of vacuolated Vps34wt-expressing cells in the presence or absence of the inhibitor was ob-
tained by inspecting N20 transfected cells per condition per experiment in three separate ex-
periments andpresented as percentage of the total number of transfected cells. *, different vs.
(−) inhibitor, P b 0.001.
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(Fig. 1D), in agreement with our previous studies for unaltered
Sac3 protein levels under PIKfyve perturbations [14,37].
3.2. The cytoplasmic vacuolation in Vps34 KO podocytes is due to PIKfyve
dysfunction
Notably, the morphological defect caused by Vps34 KO in
podocytes was phenocopied by inhibition of the PIKfyve activity in
this cell type, as observed upon treatment with the cell permeable
PIKfyve inhibitor YM201636 [5,12] (Fig. S3). This raised the ques-
tion as to whether PtdIns3P ablation in the Vps34 KO podocytes
disrupted endomembrane homeostasis indirectly, i.e., by depleting
the substrate for PIKfyve activity and, hence, PtdIns(3,5)P2 synthe-
sis. We reasoned that if this were the case, then heterologous ex-
pression of Vps34 should prevent the endomembrane defect in
Vps34 KO podocytes, but only if the latter harbor an intact PIKfyve
activity. Likewise, increased PIKfyve protein should restore the ab-
errant phenotype back to normal only in Pikfyve KO MEFs but not
in Vps34 KO podocytes. As illustrated in Fig. 2A, panels a and b, mor-
phological inspection of Vps34 KO podocytes positive for YFP-
Vps34wt ﬂuorescence signals from three independent experiments
revealed the absence of vacuoles in practically all transfected cells
(Fig. 2B), consistent with the restored PtdIns3P pool and the down-
stream PIKfyve function. However, if cells were acutely treated with
YM201636, expressed YFP-Vps34wt failed to rescue the vacuolation
(Fig. 2A, panels c and d), which was observed in ~98% of transfected
cells (Fig. 2B). Likewise, similar expression of YFP-Vps34wt in
Pikfyve KO MEFs was ineffective as evidenced by sustained aberrant
vacuolation in all transfected cells 24–48 h post-transfection
(Fig. 2A, panels e and f, and Fig. 2B). We next increased levels of
PIKfyve in Vps34 KO and Pikfyve KO cells by adenovirus-mediated
gene delivery of PIKfyvewt. This approach was fully effective only
in Pikfyve KO cells (see below). These data, together with other pub-
lished observations (see discussion), suggest that under basal con-
ditions, the cytoplasmic vacuolation in the Vps34 KO podocytes is
due to PIKfyve-dependent loss of PtdIns(3,5)P2 synthesis and that
the Vps34-catalyzed PtdIns3P pool is the main source for the
PIKfyve function in the maintenance of endomembrane homeosta-
sis in podocytes.
3.3. Vps34-produced PtdIns3P is a major membrane recruitment signal for
PIKfyve
In addition to serving as an enzyme substrate, endosomal PtdIns3P
represents a major determinant for PIKfyve membrane localization
that is mediated through the PI3P-binding FYVE domain in PIKfyve
[16]. Membrane recruitment is critical for PIKfyve functionality as
evidenced by the inability of the kinase-deﬁcient dominant-negative
point mutant PIKfyveK1831 harboring a disrupted FYVE domain to trig-
ger cytoplasmic vacuolation [9]. To determine whether Vps34 catalytic
activity is also supplying the PIKfyve localization signal, we used the
2xFYVEPIKfyve biosensor that avidly localized to PtdIns3P/EEA1-
enriched vesicular structures in Pikfyvewt/wt MEFs [14]. In agreement
with our previous data, transient transfection of eGFP–2xFYVEPIKfyve
in Pikfyve KO MEFs or Vps34ﬂ/ﬂ podocytes showed a similar vesicular
localization (Fig. 3, panels c and d, and not shown). By contrast, the
eGFP–2xFYVEPIKfyve ﬂuorescent signals in Vps34 KO podocytes were
mostly diffuse (Fig. 3, panels a and b), although vesicle association
could still be observed in some vacuolated cells (~25% of the cells).
These data corroborate the notion that PtdIns3P produced by Vps34 is
also a major membrane recruitment signal for PIKfyve. The sparse
eGFP–2xFYVEPIKfyve-positive vesicles seen in some cells support the
idea for additional sources of localized PtdIns3P production, as also
has been recently concluded in Vps34KOMEFs by usage of an enhanced
FYVE domain probe [43].
Fig. 3. 2xFYVE vesicular pattern is rendered diffuse in Vps34 KO podocytes. On day 4 post-
Ad–Cre-treatment, Vps34 KO podocytes and Pikfyve KO MEFs were transfected with
pEGFP–2xFYVEPIKfyve cDNA for visualizing PtdIns3P-enriched endosomal structures. 24 h
post-transfection cells were ﬁxed for ﬂuorescence microscopy (panels a and c) and
phase-contrast inspection (panels b and d). White arrows denote transfected cells. The
2xFYVEPIKfyve ﬂuorescence signals were diffuse in the transfected Vps34 KO podocytes
(panel a), whichwas observed in 77± 4% of transfected Vps34 KO podocytes. The ﬂuores-
cence appearance of 2xFYVEPIKfyve in the transfected PikfyveKOMEFswas vesicular (panel
c), seen in 93 ± 3% of transfected cells. Quantitation was obtained by counting N20
transfected cells per condition per experiment in 3 separate experiments. Bar, 10 μm.
1245O.C. Ikonomov et al. / Biochimica et Biophysica Acta 1853 (2015) 1240–12503.4. Commensurate decreases in steady-state levels of PtdIns3P, PtdIns5P
and PtdIns(3,5)P2 in Vps34 KO podocytes
The data presented above indicate that PIKfyve is a major down-
stream effector of Vps34-catalyzed localized PtdIns3P production in
the maintenance of endomembrane homeostasis. However, a Vps34-
independent PtdIns3P pool, generated directly or indirectly by class I
and class II PI3Ks could be quite substantial (up to 65% of total PtdIns3P
by the combined two activities) [6,22,23,43,45]. To reveal the extent of
Vps34 contribution to the PtdIns3P pool in Vps34 podocytes and the
proportion of Vps34-catalyzed PtdIns3P used by the PIKfyve catalytic
activity, we measured steady-state levels of PIs by HPLC inositol head-
group analysis subsequent to cell labeling with myo-[2-3H]inositol. As
illustrated in Fig. 4, selective and signiﬁcant changes were observed
only in steady-state levels of PtdIns3P, PtdIns5P and PtdIns(3,5)P2, con-
sistent with the key role of Vps34 in PIKfyve functionality. Steady-state
levels of PtdIns(4,5)P2 and PtdIns4P remained unaltered (Fig. 4). In
agreement with the HPLC proﬁles of PIs in other quiescent cells [5,14],
PtdIns(3,4)P2 and PtdIns(3,4,5)P3 were not detected. Data from three
separate labeling experiments in Vps34 KO vs. Vps34ﬂ/ﬂ control
podocytes revealed that steady-state levels of PtdIns3P were reduced to
~45% of the control levels, with comparable diminution in PtdIns(3,5)P2
(~40%) and PtdIns5P (~41%) (Fig. 4). Of note, during the labeling proce-
dure, a relative increase (up to 20–25%) of non-vacuolated cells (presum-
ably, expressing some Vps34) in parallel with preferential death of
vacuolated Vps34 KO podocytes has occurred. Therefore, if we normalize
for the total number of vacuolating cells seen at the end of cell labeling,
the values of the residual amounts of these lipids are overestimated by
~20–25%.
Consistent with the failure of PIKfyve membrane recruitment
under localized depletion of PtdIns3P, a step critical for formation
of productive complex of PIKfyve with its protein partners and,hence, activation of PIKfyve lipid kinase [1,46], we observed similar
reduction in both PIKfyve lipid products PtdIns5P and PtdIns(3,5)P2
(Fig. 4). Taken together, the data for residual PtdIns3P levels even
after normalization and roughly commensurate residual levels of
PtdIns(3,5)P2 and PtdIns5P by Vps34 KO suggest that: 1) in podocytes,
the Vps34-independent pathway(s) could synthesize a small propor-
tion of basal PtdIns3P and, 2) this alternatively synthesized PtdIns3P
pool could, at least in part, serve as a catalytic precursor and localization
signal for PIKfyve.
3.5. Sustained activation of class I PI3Ks delays the vacuolation phenotype
in Vps34 KO podocytes
Our ﬁndings that the vacuolation phenotype in Vps34 KO podocytes
is mainly due to PIKfyve dysfunction provided a paradigm to address
the question as to whether PIKfyve could utilize PtdIns3P produced by
class I PI3Ks, found previously to indirectly feed into the endosomal
PtdIns3P pool [47]. We took advantage of the fact that activation
of class I PI3Ks is a common cellular survival response to diverse viral
infections [48], with the non-replicating E1/E3-deleted adenoviral
vector type 5 causing sustained activation, beginning 10 min
subsequent to virus binding to its receptors and persisting for over
24 h [49–52].We reasoned that if class I PI3Kswere to provide PtdIns3P
for PIKfyve function, then adenovirus infection of Vps34 KO should
mitigate the susceptibility of cytoplasmic vacuole formation. To this
end, we used E1/E3-deleted adenoviral vector type 5 harboring GFP
(AdGFP) to facilitate detection of infected cells byﬂuorescentmicroscopy
(Fig. 5). Remarkably, AdGFP infection of Vps34 KO cells on day 4 post-
Ad–Cre treatment, a time point when the vacuolated cells were
~50% (see Fig. 1), led to a statistically signiﬁcant time delay of
vacuole formation at the 16 h, and less so, at the 36 h post-infection
vs. non-infected neighboring Vps34 KO cells on the same dish
(Fig. 5A and C). Intriguingly, if wortmannin was present during
the 16 h AdGFP infection, such a delay was not apparent (Fig. S4). Di-
rect measurement of class I PI3K activity in Vps34 KO podocytes
subsequent to the 16 h AdGFP infection revealed on average 15 and
50% elevation in PtdIns3P product in p85 and phospho-tyrosine
immunoprecipitates, respectively, in comparison to non-treated
Vps34 KO podocytes (Fig. S5), consistent with activated class I PI3K
underlying the vacuolation delay.
Contrary to Vps34 KO cells, similar AdGFP infection of Pikfyve KO cells
failed to delay the vacuolation phenotype (Fig. 5A and C), consistent
with lack of PtdIns(3,5)P2 production in PIKfyve's absence. Conversely,
introduction of AdGFP that simultaneously expresses PIKfyvewt from an
independent promoter (AdGFP–PIKfyvewt) on day 4 of the KO resulted
in nearly complete and sustained rescue of the vacuolation phenotype
in Pikfyve KO MEFs (Fig. 5B and D), in agreement with studies utilizing
other approaches for PIKfyve perturbation/vacuolation rescue [9,11].
However, AdGFP–PIKfyvewt infection of Vps34 KO podocytes produced
only a transient delay of cytoplasmic vacuolation, quantitatively similar
to that observed by the AdGFP infection (Fig. 5C and D), further reinforc-
ing the conclusion from Fig. 2 that PtdIns3P substrate deprivation and
reduced PtdIns(3,5)P2 synthesis by PIKfyve are causing the
endomembrane defect. Combined data support the notion that under
induced conditions, class I PI3Ks could deliver to some extent the
PtdIns3P precursor for PIKfyve function.
4. Discussion
The observation that perturbations of the PIKfyve kinase trigger
aberrant cell morphology in the form of translucent cytoplasmic
vacuoles, readily reversed by exogenous PtdIns(3,5)P2 delivery, together
with unavailability of sufﬁciently speciﬁc probes for PtdIns(3,5)P2
cellular detection, has promoted the cytoplasmic vacuolation phenotype
as a sensitive functional measure of localized PtdIns(3,5)P2 reduction [1,
2]. Intriguingly, similar translucent vacuoles accompanied by
Fig. 4. Reduced PIKfyve lipid products inVps34 KOpodocytes. Vps34ﬂ/ﬂ podocytes, seeded on 35mmdishes,were treatedwith Ad–Cre or Ad in complete culturemedia, as described under
“Materials andMethods”. On day 4 post-treatment media was replaced with inositol/glucose-free media for 24 h, followed bymyo-[2-3H]inositol labeling for 26 h. Lipids were extracted,
deacylated and fractionated by HPLC. Shown is quantitation from three independent experiments, calculated as a percentage of the total PI radioactivity and presented asmean± SE. The
total PI radioactivity was obtained by summing the counts within the elution times corresponding to the indicated [3H]GroPIns peaks. *, PtdIns(3,5)P2, PtdIns5P and PtdIns3P in Vps34 KO
vs. those in Vps34ﬂ/ﬂ podocytes, P b 0.05.
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been recently reported in cells derived from mouse models with
conditional Vps34 gene disruption [30–32]. Importantly, in podocyte-
speciﬁc Vps34 KO mice, the aberrant vacuolation phenotype and
disrupted endocytic trafﬁcking precede the early-age severe proteinuria
and glomerulosclerosis that lead to premature death [31,53]. As
deﬁcient autophagy is reportedly not the primary cause of the severe
defects in podocytes or in other cells and tissues with Vps34-
deﬁciency [30–32], elucidating the molecular mechanism(s) causing
the faulty performance of the endosomal system is of critical impor-
tance. The current study was undertaken to determine, ﬁrst, if the
Vps34 KO-triggered endomembrane defect in podocytes is secondary
to PIKfyve dysfunction and, hence, loss of PtdIns(3,5)P2 production
and, second, the degree to which Vps34 activity is responsible for
providing PtdIns3P as a catalytic substrate and membrane localization
signal for the constitutive PIKfyve function in this cell type. The key
ﬁndingwepresentedhere is that in podocytes, Vps34 is themain supplier
of PtdIns3P that serves as both a substrate for PIKfyve lipid kinase activity
and an endosome targeting signal for PIKfyvemembrane recruitment.We
further revealed that the cytoplasmic vacuolation seen upon Vps34 KO in
podocytes results from loss of PIKfyve downstream function due to
substrate deprivation and enzymemislocalization.We also demonstrated
that induction of class I PI3Ks in the background of Vps34KO in podocytes
can transiently restore the PIKfyve function. Our results provide the ﬁrst
experimental evidence that the Vps34 catalytic activity is the main
PtdIns3P supplier for PIKfyve functionality, at least in podocytes, and
that the aberrant cytoplasmic vacuolation seen by Vps34 disruption is
secondary to PIKfyve dysfunction.
Several lines of evidence in the current study support the conclusion
that dysregulated endomembrane homeostasis in Vps34-deﬁcient cellsis due to deﬁciency of PtdIns(3,5)P2 synthesis by PIKfyve. Thus, unlike
PIKfyve, increased protein levels of Vps34 were able to restore the
normal morphology in Vps34 KO podocytes, but only if the endogenous
PIKfyve activity was intact (Fig. 2). Conversely, increased protein levels
of PIKfyve but not of Vps34 in PikfyveKOMEFs produced a complete and
sustained restoration of the normal endomembrane morphology
(Fig. 5). Concordantly, PtdIns(3,5)P2 levels were profoundly reduced
in Vps34 KO podocytes (Fig. 4). Additional support that reduced
PtdIns(3,5)P2, rather than PtdIns3P synthesis, causes the cytoplasmic
vacuolation is provided by ﬁndings for marked decreases of PtdIns3P
under increased PIKfyve activity and elevated PtdIns(3,5)P2 synthesis,
yet vacuole formation is not apparent as seen in HEK293 cells infected
with Ad–PIKfyvewt [9]. In the same vein, unlike with PtdIns(3,5)P2,
delivery of exogenous PtdIns3P in COS cells, vacuolated due to
ectopically expressed PIKfyve dominant-negative kinase-deﬁcient
point mutant K1831, did not rescue the phenotype [10].
Our observations for similar and substantial reduction in steady-
state levels of PtdIns3P and PtdIns(3,5)P2 in Vps34 KO podocytes
(Fig. 4) allow the conclusion that Vps34 provides a considerable
subfraction of PtdIns3P as a substrate for PIKfyve enzymatic activity
(~65–70% after normalization for the total Vps34 KO cell number, see
text to Fig. 4). The observed diffuse cytosolic pattern of the PtdIns3P
reporter 2xFYVEPIKfyve (Fig. 3) indicates that Vps34-generated PtdIns3P
also serves as a major targeting signal for PIKfyve membrane recruit-
ment. The ramiﬁcation of the lost PIKfyve endosome localization is
a commensurate reduction of PtdIns5P production (Fig. 4), a ﬁnding
consistent with reported direct PIKfyve-catalyzed synthesis of
PtdIns5P [46,54]. The concomitant PtdIns5P diminution suggests
that the cytosolic PIKfyve fails to gain access to the PtdIns substrate
on membranes and/or form a productive heterooligomeric complex
Fig. 5. Transient activation of class I PI3Ks selectively delays the cytoplasmic vacuolation only in Vps34 KO podocytes. A and B, on day 4 post-Ad–Cre treatment Vps34 KO podocytes and Pikfyve
KOMEFswere infectedwith either AdGFP (A) or AdGFP–PIKfyvewt (B) atMOI=10, as described under “Materials andmethods”. 16–36 h post-infection, cellswere observed live by ﬂuorescence
and phase-contrastmicroscopymonitoring theGFP signals and the vacuolation phenotype in both infected [GFP(+)] andnoninfected [GFP(−)] cells. A,ﬂuorescence andphase-contrast images
of representative cells at 16 h post-infection showing AdGFP-infected Vps34 KO podocytes (panels a and b) that did not exhibit cytoplasmic vacuoles in contrast to the GFP(−) neighboring cells
and AdGFP-infected Pikfyve KOMEFs, inwhich the vacuolation phenotypewas unaltered (panels c and d). See C for quantiﬁcation. Bar, 10 μm. B, ﬂuorescence and phase-contrast images of rep-
resentative cells at 16 h post-infection with AdGFP–PIKfyvewt showing the absence of vacuolation in AdGFP–PIKfyvewt-expressing Vps34 KO podocytes (panels a and b) and Pikfyve KO MEFs
(panels c and d). In both cell lines the aberrant vacuoles persisted in theGFP(−) neighboring cells. See D for quantiﬁcation. Bar, 10 μm. C andD, quantiﬁcation of vacuolation in the non-infected
GFP(−) control cells (white bars) andGFP(+)-infected condition (graybars) as percentage of total GFP(−) control cells and total GFP(+) cells, respectively by countingN100 cells per condition
in three separate experiments. *, different vs. GFP(−) cells at the same time point; #, different vs. the 16 h time point, P b 0.001.
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regulator ArPIKfyve and the antagonistic PtdIns(3,5)P2 phosphatase
Sac3 [1,37,55]. Both membrane recruitment and the PAS complex
formation are crucial steps for PIKfyve activity, as evidenced by
the inability of the dominant-negative kinase-deﬁcient point
mutant PIKfyveK1831 to trigger the vacuolation phenotype if
incapacitated for PtdIns3P binding or ArPIKfyve–Sac3 association
through truncated mutations in the FYVE domain or ArPIKfyve–Sac3
interaction sites, respectively [9,56]. Concordantly, gene disruption of
ArPIKfyve or Sac3 impairs PtdIns5P synthesis, further reinforcing
the prerequisite of intact PAS complex in PIKfyve-catalyzed PtdIns5P
production [reviewed in [46,54]].
Previous studies in cells of kidney origin have indicated the key role
of PIKfyve and Vps34 in the progression of endocytic trafﬁcking, with
ﬂuid-phase endocytosis being particularly sensitive to PIKfyve or
Vps34 dysfunction [31,44]. In addition to similar endomembrane
vacuolation and endocytic trafﬁcking defects upon Vps34 or PIKfyve
perturbations, cells with genetic Vps34 KOmay exhibit defects in au-
tophagy. Reportedly, the latter could precede or follow the
endomembrane dysfunction, with differences likely related to the
cell type, the strategy in the Vps34 gene targeting, and/or the
mouse genetic background. For example,MEFs isolated from two inde-
pendent conditional Vps34 KO mouse models [30,33] exhibit different
phenotypes. Indeed, whereas MEFs from the Vps34ﬂ/ﬂ model used by
Jaber et al. form severe cytoplasmic vacuoles at early stage of excision
with Cre recombinase (5–6 days) [30], those derived from the Vps34ﬂ/ﬂ
model of Zhou et al. [33] vacuolate only after prolonged ablation of
Vps34 [herein, Fig. 1 and [43], 14–15 days]. Intriguingly, in the latter
case, theMEFs exhibit predominant autophagic defects [43]. By contrast,
Vps34disruption causes predominantly endocytic dysfunction in sensory
neurons, podocytes (Fig. 1) or lens cells [31–33]. Consistentwith this, our
observations in Vps34 KO podocytes at the ultrastructural level failed to
reveal double-membrane autophagic structures (Fig. 1C). Instead, large
swollen empty vacuoles were the most pronounced defect in these
cells. These data suggest that the autophagic and endocytic phenotypes
seen upon Vps34 KO have separate molecular mechanisms and are con-
sistent with the Vps34 endocytic functions being delivered predomi-
nantly by PIKfyve. Whereas our data indicate that the latter mechanism
operates in podocytes, it is conceivable that it has a more general signif-
icance. Future studies should deﬁne plausible cell speciﬁcity in the re-
quirement of Vps34-dependent PtdIns3P synthesis for PIKfyve
function in maintaining endomembrane homeostasis.
Class II PI3Ks that regulate key processes in different cell types, in-
cluding autophagy, hormonal and immune responses, cilia movements
and glomerular ﬁltration, also supply the constitutive PtdIns3P pool [6,
23,43,45,57]. The observations for residual PtdIns3P, as documented in
Vps34 KO podocytes (Fig. 4) or MEFs [43], derived from the same
Vps34ﬂ/ﬂ mouse model, together with the ubiquitous distribution of
class II PI3K–C2α/β, are consistent with the latter feeding endosomal
PtdIns3P for PIKfyve function. Although this has not been addressed in
our study, evidence for such a pathway has been recently provided by
ﬁndings for concurrent, though small, decreases in PtdIns3P and
PtdIns(3,5)P2 upon PI3K–C2α knock-down in 3T3L1 adipocytes [6].
Whereas the degree of PtdIns3P contribution by class II PI3Ks is a
matter of future investigation, in the framework of this study we have
provided evidence for a Vps34-independent pathway, comprised of
activated class I PI3Ks, supplying the substrate for PIKfyve in Vps34 KO
podocytes. Intriguingly, a Rab5-regulated enzyme cascade, comprised
of class I PI3Kβ and two phosphatases (PI 5- and PI 4-phosphatase),
has been suggested to generate as much as 30% of the endosomal
PtdIns3P pool [22]. Under our experimental paradigm of temporary
activation of class I PI3Ks, we observed a transient delay of the
endomembrane defects in Vps34KO podocytes in parallel with elevated
class I PI3K activity (Fig. 5 and Fig. S5), corroborating the notion of a
class I PI3K-related endosomal PtdIns3P pool being used for
PtdIns(3,5)P2 production. That this pathway could be physiologicallysigniﬁcant is inferred by the comparable phenotypes between mice
with muscle-speciﬁc KO of Pikfyve (MPIfKO) and those with muscle-
speciﬁc inactivation of Pik3r1 combined with global KO of Pik3r2
(pik3r1 mKO pik3r2-/-) [58,59] (note that both models are generated
by the same muscle–creatine kinase (MCK) promoter-driven Cre
recombinase and on C57Bl6 background). The two mouse models
share remarkably similar metabolic abnormalities, including systemic
glucose intolerance, muscle insulin resistance and increased adiposity.
This suggests that the metabolic defects in the pik3r1 mKO pik3r2-/-
mice might be related, in part, to ablation of a class I PI3K-dependent
PtdIns3P pool that serves as a precursor for PIKfyve function. These
data becomemoreprominent in light ofﬁndings for distinct phenotypes
in mice with muscle-speciﬁc Vps34 KO [30,60] (also controlled by the
same MCK promoter-driven Cre recombinase and on Bl6 background)
and MPIfKO [59]. Indeed, MPIfKO mice have normal life span and size
of heart or striated muscles [59], whereas muscle-speciﬁc Vps34 KO
causes premature death at 2–4 months of age, enlarged heart and
striated muscular dystrophy [30,60]. The more severe mouse pheno-
types upon muscle-speciﬁc Vps34 KO suggest that if the Vps34-
catalysed PtdIns3P pool is also a main substrate supplier for PIKfyve
functionality inmuscle cells, as observed herein for podocytes, only a
subfraction of this pool undergoes the PAS complex-dependent
PtdIns3P–PtdIns(3,5)P2 cycling.
In conclusion, our study demonstrates that podocytes lacking Vps34
produce an abnormal vacuolation phenotype that is due to inadequate
Vps34-dependent PtdIns3P synthesis on endosomes and consequent
PtdIns(3,5)P2/PtdIns5P reduction due to PIKfyve dysfunction. These
data are consistent with an important physiological relationship of
Vps34 and PIKfyve in podocyte endomembrane homeostasis and
maintenance of glomerular ﬁltration.
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